See All Slides - tctmd.com

Slides

Presentation TCT 2013

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

Presenter: Frederick Feit

October 31, 2013

Presentation TCT 2013

Transradial Access: If You Care About Bleeding and Survival!

Presenter: Thomas Tu

October 31, 2013

Presentation

A Collaboration in Adult Congenital Cardiac Care; Valve-in-Valve Transcatheter Edwards Sapien™ Implantation In A Degenerated Stenotic Hancock Conduit After A Fontan Björk...

Presenter: Huangling Lu

October 31, 2013

Presentation

Design and Function of Perfused Cadaveric Specimens for the Cardiovascular System

Presenter: Dmitry Levin

October 31, 2013

Presentation TCT 2013

Limus-Based Drug-Coated Balloon Platforms: Technological and Biological Challenges

Presenter: Sahil Parikh

October 31, 2013

Presentation TCT 2013

SAFE-PCI: Perspectives on Radial vs Femoral Access and Randomized in Registry Trials

Presenter: James Hermiller Jr

October 31, 2013

Presentation TCT 2013

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

Redefining Medical Education, Clinical Research, and Patient Care

Presenter: John Harold

October 31, 2013

Presentation TCT 2013

IN.PACT (Medtronic)

Presenter: Andrej Schmidt

October 31, 2013

Presentation TCT 2013

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Presenter: Reda Ibrahim

October 31, 2013

Advertisement

Slides

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

Transradial Access: If You Care About Bleeding and Survival!

A Collaboration in Adult Congenital Cardiac Care; Valve-in-Valve Transcatheter Edwards Sapien™ Implantation In A Degenerated Stenotic Hancock Conduit After A Fontan Björk...

Design and Function of Perfused Cadaveric Specimens for the Cardiovascular System

Limus-Based Drug-Coated Balloon Platforms: Technological and Biological Challenges

SAFE-PCI: Perspectives on Radial vs Femoral Access and Randomized in Registry Trials

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Redefining Medical Education, Clinical Research, and Patient Care

IN.PACT (Medtronic)

LAA Exclusion for Patients with Atrial Fibrillation: Appropriate Indications, Concerns, and Unanswered Questions

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content